Beta
ManageSearchChatDiscover
351472

Role of Intracoronary Adenosine on Prevention of No Reflow during Primary PCI in STEMI Patients Guided by MVO in CMR

Article

Last updated: 29 Dec 2024

OverviewSimilar Items

Subjects

-

Tags

-

Abstract

Microvascular obstruction (MO) or no-reflow 
phenomenon is an established complication of 
coronary reperfusion therapy for acute 
myocardial infarction. It is increasingly 
recognized as a poor prognostic indicator and 
marker of subsequent adverse LV remodeling. 
Microvascular obstruction (MO) or no-reflow 
phenomenon is an established complication of 
coronary reperfusion therapy for acute 
myocardial infarction. It is increasingly 
recognized as a poor prognostic indicator and 
marker of subsequent adverse LV remodeling. 

DOI

10.21608/cvrepj.2022.351472

Volume

6

Article Issue

1

Related Issue

47292

Issue Date

2022-06-01

Receive Date

2024-04-23

Publish Date

2022-06-01

Print ISSN

2636-4204

Online ISSN

2636-4212

Article File

CVREPJ3514721654034400.pdf

PDF . 122.7kB

Link

https://cvrepj.journals.ekb.eg/article_351472.html

Detail API

https://cvrepj.journals.ekb.eg/service?article_code=351472

Order

351,472

Type

Abstracts

Type Code

3,139

Publication Type

Journal

Publication Title

Cardiovascular Research Prove Journal

Publication Link

https://cvrepj.journals.ekb.eg/

MainTitle

Role of Intracoronary Adenosine on Prevention of No Reflow during Primary PCI in STEMI Patients Guided by MVO in CMR

Details

Type

Article

Created At

20 Dec 2024